Growth hormone receptor: Structure function relationships

Hormone Research in Paediatrics

Volumn 76, Issue SUPPL. 1, 2011, Pages 12-16

  Waters, Michael J ^a   Brooks, Andrew J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Activation mechanism; Constitutive dimer; Growth hormone receptor; Janus kinase 2; Src family kinase

Indexed keywords

ALANINE; ARGININE; CALCIUM; CYTOKINE RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPITOPE; GLYCINE; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; JANUS KINASE 2; LYSINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCLONAL ANTIBODY; PHOSPHOLIPASE C GAMMA; PROTEIN TYROSINE KINASE; RAS PROTEIN; STAT5 PROTEIN; TRYPTOPHAN;

BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL MEMBRANE; CELL SURFACE; CONFERENCE PAPER; CRYSTAL STRUCTURE; DIMERIZATION; ENERGY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE MUTATION; HORMONE BINDING; HORMONE RECEPTOR INTERACTION; HORMONE STRUCTURE; HYDROGEN BOND; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; STATIC ELECTRICITY; STRUCTURE ACTIVITY RELATION;

ANIMALS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; JANUS KINASE 2; MICE; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE KINASES; RECEPTORS, SOMATOTROPIN; SRC-FAMILY KINASES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79960732951     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000329138     Document Type: Conference Paper

References (17)

1. Lanning NJ, Carter-Su C: Recent advances in growth hormone signalling. Rev Endocr Metab Disord 2006; 7: 225-235. (Pubitemid 46399314)
2. Lichanska AM, Waters MJ: How GH controls growth, obesity and sexual dimorphism. Trends Genet 2008; 24: 41-47. (Pubitemid 350298633)
3. Clackson T, Ultsch MH, Wells JA, deVos AM: Structural and functional analysis of the 1: 1 GH:receptor complex reveals the molecular basis for receptor affinity. J Mol Biol 1998; 277: 1111-1128. (Pubitemid 28190850)
4. Walsh STR, Jevitts LM, Sylvester JE, Kossiakoff AA: Site2 binding energetics of the regulatory step of GH-induced receptor homodimerization. Protein Sci 2003; 12: 1960-1970. (Pubitemid 37022818)
5. Bernat B, Pal G, Sun M, Kossiakoff AA: Determination of the energetics governing the regulatory step in GH-induced receptor homodimerization. Proc Natl Acad Sci USA 2003; 100: 952-957. (Pubitemid 36183936)
6. Fuh G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV, Wells JA: Rational design of potent antagonists to the human GH receptor. Science 1992; 256: 1677-1680.
7. Rowlinson SW, Behncken SN, Rowland JE, Clarkson RW, Strasberg CJ, Wu Z, Baumbach W, Waters MJ: Activation of chimeric and full length GH receptor by GH receptor monoclonal antibodies. A specific conformational change may be required for full length receptor signalling. J Biol Chem 1998; 273: 5307-5314. (Pubitemid 28108697)
8. Ross RJ, Leung KC, Maamra M, Bennett W, Doyle N, Waters MJ, Ho KK: Binding and functional studies with the GH receptor antagonist, B2036PEG (pegvisomant) reveal effects of pegylation and evidence that it binds to a receptor dimer. J Clin Endocrinol Metab 2001; 86: 1716-1723. (Pubitemid 32374928)
9. Gent J, van Kerkhof P, Roza M, Bu G, Strous GJ: Ligand-independent GH receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis. Proc Natl Acad Sci USA 2002; 99: 9858-9863. (Pubitemid 34831137)
10. van Kerkhof P, Smeets M, Strous GJ: The ubiquitin-proteasome pathway regulates the availability of the GH receptor. Endocrinology 2002; 143: 1243-1252. (Pubitemid 34274353)
11. Brown RJ, Adams JJ, Pelekanos RR, Wan Y, McKinstry WJ, Palethorpe K, Seeber RM, Monks TA, Eidne KA, Parker MW, Waters MJ: Model for GH receptor activation based on subunit rotation within a receptor dimer. Nat Struct Mol Biol 2005; 12: 814-821. (Pubitemid 43086257)
12. Chen C, Brinkworth R, Waters MJ: The role of receptor dimerization domain residues in GH signalling. J Biol Chem 1997; 272: 5133-5140. (Pubitemid 27090070)
13. Gent J, Vanden Eijnden M, van Kerkhof P, Strous GJ: Dimerization and signal transduction of the GH receptor. Mol Endocrinol 2003; 17: 967-975.
14. Wan Y, Zheng YZ, Harris JM, Brown R, Waters MJ: Epitope map for a GH receptor agonist monoclonal antibody, MAb 263. Mol Endocrinol 2003; 17: 2240-2250. (Pubitemid 37352535)
15. Rowlinson SW, Yoshizato H, Barclay JL, Brooks AJ, Behncken SN, Kerr LM, Millard K, Palethorpe K, Nielsen K, Clyde-Smith J, Hancock JF, Waters MJ: An agonist-induced conformational change in the GH receptor determines the choice of signalling pathway. Nat Cell Biol 2008; 10: 740-747. (Pubitemid 351780137)
16. Lewis MD, Horan M, Millar DS, Newsway V, Easter TE, Fryklund L, Gregory JW, Norin M, Del Valle CJ, López-Siguero JP, Cañete R, López-Canti LF, Díaz-Torrado N, Espino R, Ulied A, Scanlon MF, Procter AM, Cooper DN: A novel dysfunctional GH variant (Ile179Met) exhibits a decreased ability to activate the ERK pathway. J Clin Endocrinol Metab 2004; 89: 1068-1075. (Pubitemid 38368392)
17. Thompson BJ, Shang CA, Waters MJ: Identification of genes induced by GH in liver using cDNA arrays. Endocrinology 2000; 141: 4321-4324.